Trevi Therapeutics, Inc. (TRVI)
Data as of , from SEC Form 4 filings.
See up to 3 months of TRVI. The 7-day demo opens the 1M and 3M ranges and puts TRVI on your watchlist.
Start 7-day demoLatest TRVI insider trades
Michael Thomas Heffernan - DirectorOpen-market sale$276K- Michael Thomas Heffernan - DirectorOpen-market sale$2K
About Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. is an SEC registrant, filing under CIK 0001563880, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
TRVI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 39,473 | $596K |
| Option exercise | 4 | 78,946 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
TRVI insider transactions (Form 4)
2718 Form 4 filings on record, the earliest from Oct 1, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Michael Thomas Heffernan - Director | Option exercise | Common Stock | 18,421 | $3.04 | $56K | |
| Michael Thomas Heffernan - Director | Open-market sale | Common Stock | 18,321 | $15.09 footnote F2 | $276K | |
| Michael Thomas Heffernan - Director | Open-market sale | Common Stock | 100 | $15.88 | $2K | |
| Michael Thomas Heffernan - Director | Option exercise | Common Stock | 21,052 | $3.33 | $70K | |
| Michael Thomas Heffernan - Director | Open-market sale | Common Stock | 20,952 | $15.09 footnote F2 | $316K | |
| Michael Thomas Heffernan - Director | Open-market sale | Common Stock | 100 | $15.88 | $2K | |
| Michael Thomas Heffernan - Director | Option exercise | Stock Option (right to buy) | 18,421 | $0.00 | - | |
| Michael Thomas Heffernan - Director | Option exercise | Stock Option (right to buy) | 21,052 | $0.00 | - | |
| ||||||
| Edward T. Mathers | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Dominick Colangelo | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 | - | |
| David P. Meeker | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Anne Vanlent | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Michael Thomas Heffernan | Grant or award | Nonstatutory Stock Option (right to buy) | 35,000 | $0.00 | - | |
| James V. Cassella - Officer | Grant or award | Stock Option (right to buy) | 215,000 | $0.00 | - | |
| Christopher Galletta - Officer | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Thomas Sciascia - Officer | Grant or award | Stock Option (right to buy) | 85,000 | $0.00 | - | |
| Jennifer L. Good - Officer | Grant or award | Stock Option (right to buy) | 675,000 | $0.00 | - | |
| Farrell Simon - Officer | Grant or award | Stock Option (right to buy) | 160,000 | $0.00 | - | |
| David C. Hastings - Officer | Grant or award | Stock Option (right to buy) | 375,000 | $0.00 | - | |
| Christopher Galletta - Officer | Option exercise | Common Stock | 4,225 | $0.51 | $2K | |
| Christopher Galletta - Officer | Option exercise | Stock Option (right to buy) | 4,225 | $0.00 | - | |
| Anne Vanlent | Grant or award | Nonstatutory Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Thomas Sciascia - Officer | Grant or award | Performance Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Jennifer L. Good - Officer | Grant or award | Performance Stock Option (right to buy) | 102,000 | $0.00 | - | |
| Christopher Galletta - Officer | Option exercise | Common Stock | 15,000 | $0.51 | $8K | |
| Christopher Galletta - Officer | Option exercise | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| James V. Cassella - Officer | Grant or award | Stock Option (right to buy) | 400,000 | $0.00 | - | |
Recent TRVI Form 144 notices of proposed sale
1An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| MICHAEL HEFFERNAN | Director | 39,473 | $627K | View on EDGAR |
TRVI insider trading FAQ
What is the latest insider trade for TRVI?
Trevi Therapeutics, Inc. (TRVI) had 1 insider filing in the last 90 days, with the most recent on 2026-09-17. The full record for TRVI runs to 18 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TRVI stock?
No insider purchases of TRVI were filed in the last 90 days.
How many insiders are selling TRVI stock?
4 insider sales of TRVI were filed in the last 90 days, totaling $596K.
Where can I see TRVI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TRVI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael Thomas Heffernan view on EDGAR
- - Edward T. Mathers view on EDGAR
- - Dominick Colangelo view on EDGAR
- - David P. Meeker view on EDGAR
- - Anne Vanlent view on EDGAR
- - Michael Thomas Heffernan view on EDGAR
- - James V. Cassella view on EDGAR
- - Christopher Galletta view on EDGAR
- - Thomas Sciascia view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where TRVI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TRVI with a 7-day demo
- TRVI on your watchlist
- Every TRVI Form 4 filing on record
- Up to 3 months of TRVI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
